QUESTIONABLE PHARMA: EXAMINING THE ISSUES

The term " Disreputable Pharma" has surfaced recently, igniting a heated debate surrounding specific pharmaceutical entities. Allegations of misleading marketing strategies , inflated drug costs , and a apparent disregard for patient safety have resulted in increasing criticism from regulators ,